Table 3.

Dose alteration and number of users of the used systemic immunosuppressants during the 12-week study period and at longer follow-up

		12 weeks		Follow-up
Systemic immuno-suppressant		n users (%)	Dose change in mg/day, median (range)	n users (%)	Dose change in mg/day, median (range)
Prednisolone	Total	39 (100)		39 (100)
	Reduction	23 (59)	20 (88)	30 (77)	20 (75)
	Increase	1 (3)	20 (0)	5 (13)	20 (23)
Tacrolimus	Total	20 (100)		19 (100)
	Reduction	7 (35)	2 (2)	11 (58)	2 (3)
	Increase	4 (20)	2 (1)	3 (16)	1 (1)
Cyclosporin	Total	17 (100)		17 (100)
	Reduction	3 (18)	100 (88)	13 (76)	100 (250)
	Increase	2 (12)	100 (100)	3 (18)	100 (50)